Cited by 220Cell Adhesion Molecules ResearchEffects of Radiation ExposurePI3K/AKT/mTOR signaling in cancer

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

β1 Integrin Inhibition Dramatically Enhances Radiotherapy Efficacy in Human Breast Cancer Xenografts

Open access

Park, Catherine C., Zhang, Hui J., Yao, Evelyn S., Park, Chong J., Bissell, Mina J.·2008·Cancer Research

DOI 10.1158/0008-5472.can-07-6390PMC PMC3719863

Open this paper in CoChat — free account Open PDF

Abstract

β1 Integrin signaling has been shown to mediate cellular resistance to apoptosis after exposure to ionizing radiation (IR). Other signaling molecules that increase resistance include Akt, which promotes cell survival downstream of β1 integrin signaling. We previously showed that β1 integrin inhibitory antibodies (e.g., AIIB2) enhance apoptosis and decrease growth in human breast cancer cells in three-dimensional laminin-rich extracellular matrix (lrECM) cultures and in vivo. Here, we asked whether AIIB2 could synergize with IR to modify Akt-mediated IR resistance. We used three-dimensional lrECM cultures to test the optimal combination of AIIB2 with IR treatment of two breast cancer cell lines, MCF-7 and HMT3522-T4-2, as well as T4-2 myr-Akt breast cancer colonies or HMT3522-S-1, which form normal organotypic structures in three-dimensional lrECM. Colonies were assayed for apoptosis and β1 integrin/Akt signaling pathways were evaluated using Western blot. In addition, mice bearing MCF-7 xenografts were used to validate the findings in three-dimensional lrECM. We report that AIIB2 increased apoptosis optimally post-IR by down-regulating Akt in breast cancer colonies in three-dimensional lrECM. In vivo, addition of AIIB2 after IR significantly enhanced tumor growth inhibition and apoptosis compared with either treatment alone. Remarkably, the degree of tumor growth inhibition using AIIB2 plus 2 Gy radiation was similar to that of 8 Gy alone. We previously showed that AIIB2 had no discernible toxicity in mice; here, its addition allowed for a significant reduction in the IR dose that was necessary to achieve comparable growth inhibition and apoptosis in breast cancer xenografts in vivo. [Cancer Res 2008;68(11):4398–405]

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-07-6390

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Untitled work
Hynes (2002) · doi:10.1016/s0092-8674(02)00971-6 · Cited by 8,606
Integrin signaling
Giancotti, F. G., & Ruoslahti, E. (1999) · Science · doi:10.1126/science.285.5430.1028 · Cited by 3,869
Reversion of the Malignant Phenotype of Human Breast Cells in Three-Dimensional Culture and In Vivo by Integrin Blocking Antibodies
Weaver, V. M., Petersen, O. W., Wang, F., Larabell, C. A., Briand, P., Damsky, C., & Bissell, M. J. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.137.1.231 · Cited by 1,483
Self-citation
Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression.
Werb, Z., Tremble, P., Behrendtsen, O., Crowley, E., & Damsky, C. H. (1989) · The Journal of Cell Biology · doi:10.1083/jcb.109.2.877 · Cited by 1,057
Cell Adhesion Mediated Drug Resistance (CAM-DR): Role of Integrins and Resistance to Apoptosis in Human Myeloma Cell Lines
Damiano, J. S., Cress, A. E., Hazlehurst, L., Shtil, A. A., & Dalton, W. S. (1999) · Blood · doi:10.1182/blood.v93.5.1658 · Cited by 899
Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation.
Brognard, J., Clark, A. S., Ni, Y., & Dennis, P. A. (2001) · PubMed · Cited by 885
The Akt-mTOR tango and its relevance to cancer
Hay, N. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.08.008 · Cited by 826
β4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium
Weaver, V. M., Lelièvre, S. A., Lakins, J. N., Chrenek, M. A., Jones, J., Giancotti, F. G., Werb, Z., & Bissell, M. J. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00125-3 · Cited by 794
Self-citation
Reciprocal interactions between β1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: A different perspective in epithelial biology
Wang, F., Weaver, V. M., Petersen, O. W., Larabell, C. A., Dedhar, S., Briand, P., Lupu, R., & Bissell, M. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14821 · Cited by 653
Self-citation
Outcome at 8 Years After Breast-Conserving Surgery and Radiation Therapy for Invasive Breast Cancer: Influence of Margin Status and Systemic Therapy on Local Recurrence
Park, C. C., Mitsumori, M., Nixon, A. J., Recht, A., Connolly, J. L., Gelman, R. S., Silver, B., Hetelekidis, S., Abner, A. L., Harris, J. R., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.8.1668 · Cited by 547
Self-citation

Show all 43 references

Sorted by citations

Items 101–200 of 220

Bisphenol S and Bisphenol A disrupt morphogenesis of MCF-12A human mammary epithelial cells
Atlas, E., & Dimitrova, V. (2019) · Scientific Reports · doi:10.1038/s41598-019-52505-x · Cited by 46
3D culture of Her2+ breast cancer cells promotes AKT to MAPK switching and a loss of therapeutic response
Gangadhara, S., Smith, C. R., Barrett-Lee, P. J., & Hiscox, S. (2016) · BMC Cancer · doi:10.1186/s12885-016-2377-z · Cited by 43
Enhanced radiosensitivity of head and neck squamous cell carcinoma cells by β1 integrin inhibition
Eke, I., Dickreuter, E., & Cordes, N. (2012) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2012.05.009 · Cited by 44
Intracellular trafficking of integrins in cancer cells
Onodera, Y., Nam, J., & Sabe, H. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.05.007 · Cited by 42
Specific β-containing Integrins Exert Differential Control on Proliferation and Two-dimensional Collective Cell Migration in Mammary Epithelial Cells
Jeanes, A. I., Wang, P., Moreno‐Layseca, P., Paul, N. R., Cheung, J., Tsang, R., Akhtar, N., Foster, F. M., Brennan, K. R., & Streuli, C. H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.360834 · Cited by 42
FOXM1 transcriptionally regulates expression of integrin β1 in triple-negative breast cancer
Hamurcu, Z., Kahraman, N., Ashour, A. A., & Özpolat, B. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4207-7 · Cited by 41
αvβ3 Integrin Mediates Radioresistance of Prostate Cancer Cells through Regulation of Survivin
Wang, T., Huang, J., Vue, M., Alavian, M. R., Goel, H. L., Altieri, D. C., Languino, L. R., & FitzGerald, T. J. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0544 · Cited by 41
Beta1 integrin blockade overcomes doxorubicin resistance in human T-cell acute lymphoblastic leukemia
Berrazouane, S., Boisvert, M., Salti, S., Mourad, W. M., Al‐Daccak, R., Barabé, F., & Aoudjit, F. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1593-2 · Cited by 41
The PI3K/mTOR inhibitor Gedatolisib eliminates dormant breast cancer cells in organotypic culture, but fails to prevent metastasis in preclinical settings
Shor, R. E., Dai, J., Lee, S., Pisarsky, L., Matei, I. R., Lucotti, S., Lyden, D. C., Bissell, M. J., & Ghajar, C. M. (2021) · Molecular Oncology · doi:10.1002/1878-0261.13031 · Cited by 39
Self-citation
Radiation sensitization of tumor cells induced by shear stress: The roles of integrins and FAK
Luo, C., Wu, C., & Ch'ang, H.-J. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.06.007 · Cited by 39
A diterpenoid compound, excisanin A, inhibits the invasive behavior of breast cancer cells by modulating the integrin β1/FAK/PI3K/AKT/β-catenin signaling
Qin, J., Tang, J., Jiao, L., Ji, J., Chen, W.-D., Feng, G., Gao, Y.-H., Zhu, X., & Deng, R. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.09.002 · Cited by 38
β1-integrin via NF-κB signaling is essential for acquisition of invasiveness in a model of radiation treated in situ breast cancer
Nam, J., Ahmed, K. M., Costes, S. V., Zhang, H., Onodera, Y., Olshen, A. B., Hatanaka, K. C., Kinoshita, R., Ishikawa, M., Sabe, H., et al. (2013) · Breast Cancer Research · doi:10.1186/bcr3454 · Cited by 39
Self-citation
Expression of ITGB1 predicts prognosis in colorectal cancer: a large prospective study based on tissue microarray.
Liu, Q., Gao, X., Chang, W.-J., Gong, H., Fu, C., Zhang, W., & Cao, G. (2015) · PubMed Central · Cited by 38
CD146 interaction with integrin β1 activates LATS1-YAP signaling and induces radiation-resistance in breast cancer cells
Liang, Y., Zhou, X., Xie, Q., Sun, H., Huang, K., Chen, H., Wang, W., Zhou, B., Wei, X., Zeng, D., et al. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215856 · Cited by 40
Cancer-associated fibroblasts in radiotherapy: Bystanders or protagonists?
Martínez-Zubiaurre, I., & Hellevik, T. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01093-5 · Cited by 36
The extracellular matrix – immune microenvironment crosstalk in cancer therapy: Challenges and opportunities
Closset, L., Gultekin, O., Salehi, S., Sarhan, D., Lehti, K., & Gonzalez‐Molina, J. (2023) · Matrix Biology · doi:10.1016/j.matbio.2023.07.003 · Cited by 36
Adhesion- and stress-related adaptation of glioma radiochemoresistance is circumvented by β1 integrin/JNK co-targeting
Vehlow, A., Klapproth, E., Storch, K., Dickreuter, E., Seifert, M., Dietrich, A., Bütof, R., Temme, A., & Cordes, N. (2017) · Oncotarget · doi:10.18632/oncotarget.17480 · Cited by 38
Resistance to the mTOR-inhibitor RAD001 elevates integrin α2- and β1-triggered motility, migration and invasion of prostate cancer cells
Tsaur, I., Makarević, J., Juengel, E., Gasser, M., Waaga-Gasser, A.-M., Kurosch, M., Reiter, M., Wedel, S., Bartsch, G. C., Haferkamp, A., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.313 · Cited by 35
Induction of Autophagic Death in Cancer Cells by Agonizing TR3 and Attenuating Akt2 Activity
Wang, W.-J., Wang, Y., Hou, P.-P., Li, F.-W., Zhou, B., Chen, H., Bian, X., Cai, Q., Xing, Y.-Z., He, J., et al. (2015) · Chemistry & Biology · doi:10.1016/j.chembiol.2015.06.023 · Cited by 34
Self-citation
Therapeutic targeting of tumor–stroma interactions
Hiscox, S., Barrett-Lee, P. J., & Nicholson, R. I. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.561201 · Cited by 33
Molecular interactions of ErbB1 (EGFR) and integrin- 1 in astrocytoma frozen sections predict clinical outcome and correlate with Akt-mediated in vitro radioresistance
Petras, M., Lajtos, T., Friedlander, E., Klekner, Á., Pintye, É., Feuerstein, B. G., Szöllõsi, J., & Vereb, G. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not046 · Cited by 35
β1 integrins mediate cell proliferation in three‐dimensional cultures by regulating expression of the sonic hedgehog effector protein, GLI1
Goel, H. L., Underwood, J. M., Nickerson, J. A., Hsieh, C., & Languino, L. R. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22116 · Cited by 31
Metastasis Update: Human Prostate Carcinoma Invasion via Tubulogenesis
Nagle, R. B., & Cress, A. E. (2011) · Prostate Cancer · doi:10.1155/2011/249290 · Cited by 31
The Inhibition of Vessel Co-Option as an Emerging Strategy for Cancer Therapy
Carrera-Aguado, I., Marcos-Zazo, L., Carrancio-Salán, P., Guerra-Paes, E., Sánchez‐Juanes, F., & Muñoz‐Félix, J. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020921 · Cited by 31
iRGD-guided tamoxifen polymersomes inhibit estrogen receptor transcriptional activity and decrease the number of breast cancer cells with self-renewing capacity
Bessone, M. I. D., Simón‐Gracia, L., Scodeller, P., Ramírez, M. D. L. Á., Huvelle, M. A. L., Soler‐Illia, G. J. A. A., & Simian, M. (2019) · Journal of Nanobiotechnology · doi:10.1186/s12951-019-0553-4 · Cited by 32
Targeting Cellular Components of the Tumor Microenvironment in Solid Malignancies
Belli, C., Antonarelli, G., Repetto, M., Bielo, L. B., Crimini, E., & Curigliano, G. (2022) · Cancers · doi:10.3390/cancers14174278 · Cited by 31
Tumor Biomechanics Alters Metastatic Dissemination of Triple Negative Breast Cancer via Rewiring Fatty Acid Metabolism
Filipe, E. C., Velayuthar, S., Philp, A. M., Nobis, M., Latham, S. L., Parker, A. L., Murphy, K. J., Wyllie, K., Major, G. S., Contreras, O., et al. (2024) · Advanced Science · doi:10.1002/advs.202307963 · Cited by 26
CD133(−) Cells, Derived From a Single Human Colon Cancer Cell Line, Are More Resistant to 5-Fluorouracil (FU) Than CD133(+) Cells, Dependent on the β1-Integrin Signaling
Hongo, K., Tanaka, J., Tsuno, N. H., Kawai, K., Nishikawa, T., Shuno, Y., Sasaki, K., Kaneko, M., Hiyoshi, M., Sunami, E., et al. (2011) · Journal of Surgical Research · doi:10.1016/j.jss.2011.03.076 · Cited by 27
Understanding the role of structural integrity and differential expression of integrin profiling to identify potential therapeutic targets in breast cancer
Das, V., Kalyan, G., Hazra, S., & Pal, M. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25821 · Cited by 26
Mechanisms of Cell Adhesion Molecules in Endocrine-Related Cancers: A Concise Outlook
Ruan, Y., Chen, L., Xie, D., Luo, T., Xu, Y., Ye, T., Chen, X., Feng, X., & Wu, X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.865436 · Cited by 26
In vivo biokinetic and metabolic characterization of the 68Ga-labelled α5β1-selective peptidomimetic FR366
D’Alessandria, C., Pohle, K., Rechenmacher, F., Neubauer, S., Notni, J., Wester, H., Schwaiger, M., Kessler, H., & Beer, A. J. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3218-z · Cited by 26
Controlled Breast Cancer Microarrays for the Deconvolution of Cellular Multilayering and Density Effects upon Drug Responses
Håkanson, M., Kobel, S., Lütolf, M. P., Textor, M., Cukierman, E., & Charnley, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040141 · Cited by 26
Long-term Tumor Adaptation after Radiotherapy: Therapeutic Implications for Targeting Integrins in Prostate Cancer
Eke, I., Makinde, A. Y., Aryankalayil, M. J., Reedy, J. L., Citrin, D. E., Chopra, S., Ahmed, M. M., & Coleman, C. N. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0232 · Cited by 25
Improving drug penetration to curb tumor drug resistance
Marcucci, F., & Corti, A. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.06.004 · Cited by 26
Focal Adhesion-Chromatin Linkage Controls Tumor Cell Resistance to Radio- and Chemotherapy
Storch, K., & Cordes, N. (2012) · Chemotherapy Research and Practice · doi:10.1155/2012/319287 · Cited by 27
Tenascin-C in the extracellular matrix promotes the selection of highly proliferative and tubulogenesis-defective endothelial cells
Alves, T. R., da Fonseca, A. C. C., Nunes, S. S., de Barros, A. O. D. S., Dubois, L. G., Faria, J., Kahn, S. A., Viana, N. B., de Souza, J. M., Legrand, C., et al. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.06.006 · Cited by 24
Le microenvironnement tumoral et la résistance thérapeutique
Borriello, L., & DeClerck, Y. A. (2014) · médecine/sciences · doi:10.1051/medsci/20143004021 · Cited by 23
hMENA isoforms impact NSCLC patient outcome through fibronectin/β1 integrin axis
Modugno, F. D., Spada, S., Palermo, B., Visca, P., Iapicca, P., Carlo, A. D., Antoniani, B., Sperduti, I., Benedetto, A. D., Terrenato, I., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0364-3 · Cited by 23
Self-citation
Prognostic and predictive impact of stroma cells defined by PDGFRb expression in early breast cancer: results from the randomized SweBCG91RT trial
Strell, C., Tullberg, A. S., Edelmann, R. J., Akslen, L. A., Malmström, P., Fernö, M., Holmberg, E. C., Östman, A., & Karlsson, P. (2021) · Breast Cancer Research and Treatment · doi:10.1007/s10549-021-06136-4 · Cited by 22
Inhibition of blood vessel formation by a chondrocyte-derived extracellular matrix
Choi, B. H., Choi, K., Lee, H. S., Song, B., Park, S. R., Yang, J. W., & Min, B. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.03.083 · Cited by 22
Effect of mechanical forces on cellular response to radiation
Lacombe, J., & Zenhausern, F. (2022) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2022.10.006 · Cited by 23
Integrins in development and cancer
Anderson, L. R., Owens, T. W., & Naylor, M. J. (2013) · Biophysical Reviews · doi:10.1007/s12551-013-0123-1 · Cited by 21
Hijacking EMT: Better Fat Than Dead
Hinz, S., & LaBarge, M. A. (2019) · Cancer Cell · doi:10.1016/j.ccell.2018.12.007 · Cited by 20
Integrin β1, Osmosensing, and Chemoresistance in Mouse Ehrlich Carcinoma Cells
Sørensen, B. H., Rasmussen, L. J. H., Broberg, B., Klausen, T. K., Sauter, D. R. P., Lambert, I. H., Aspberg, A., & Hoffmann, E. K. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000374057 · Cited by 20
High-level β1-integrin expression in a subpopulation of highly tumorigenic oral cancer cells
Lin, H., Wu, C., Chen, Y., Huang, J.-S., Wong, T.-Y., & Yuan, K. (2013) · Clinical Oral Investigations · doi:10.1007/s00784-013-1088-y · Cited by 19
Effect of cancer-associated fibroblasts on radiosensitivity of cancer cells
Ji, X., Zhu, X., & Lu, X. (2017) · Future Oncology · doi:10.2217/fon-2017-0054 · Cited by 18
Integrins as Key Mediators of Metastasis
Cáceres-Calle, D., Torre-Cea, I., Marcos-Zazo, L., Carrera-Aguado, I., Guerra-Paes, E., Berlana-Galán, P., Muñoz‐Félix, J. M., & Sánchez‐Juanes, F. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26030904 · Cited by 22
Ligand-induced Epitope Masking
Mould, A. P., Askari, J. A., Byron, A., Takada, Y., Jowitt, T. A., & Humphries, M. J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.736942 · Cited by 17
Organotypic Spheroid Culture to Mimic Radiation-Induced Salivary Hypofunction
Shin, H. S., An, H., Choi, J., Kim, H. J., & Lim, J. (2017) · Journal of Dental Research · doi:10.1177/0022034516685036 · Cited by 17
Dual effects of radiotherapy on tumor microenvironment and its contribution towards the development of resistance to immunotherapy in gastrointestinal and thoracic cancers
Zhao, D., Mo, Y., Неганова, М. Е., Aleksandrova, Y. R., Tse, E., Chubarev, V. N., Fan, R., Sukocheva, O. A., & Liu, J. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1266537 · Cited by 18
Modulation of radiation-induced oral mucositis (mouse) by selective inhibition of β1 integrin
Albert, M. L., Schmidt, M., Cordes, N., & Dörr, W. (2012) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2012.06.010 · Cited by 16
High PDGFRb Expression Predicts Resistance to Radiotherapy in DCIS within the SweDCIS Randomized Trial
Strell, C., Folkvaljon, D., Holmberg, E. C., Schiza, A., Thurfjell, V., Karlsson, P., Bergh, J. C. S., Bremer, T. M., Akslen, L. A., Wärnberg, F., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-4300 · Cited by 16
Efficacy of Beta1 Integrin and EGFR Targeting in Sphere-Forming Human Head and Neck Cancer Cells
Zscheppang, K., Kurth, I., Wachtel, N., Dubrovska, A., Kunz‐Schughart, L. A., & Cordes, N. (2016) · Journal of Cancer · doi:10.7150/jca.14232 · Cited by 16
Radiation-assisted strategies provide new perspectives to improve the nanoparticle delivery to tumor
Zhang, D., He, J., & Zhou, M. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114642 · Cited by 16
Molecular Targets for Radiation Oncology in Prostate Cancer
Wang, T., Languino, L. R., Lian, J. B., Stein, G. S., Blute, M. L., & FitzGerald, T. J. (2011) · Frontiers in Oncology · doi:10.3389/fonc.2011.00017 · Cited by 15
Polymeric Delivery of siRNA against Integrin‐β1 (CD29) to Reduce Attachment and Migration of Breast Cancer Cells
Sundaram, D. N. M., Kucharski, C., Parmar, M. B., Bahadur, K., & Uludağ, H. (2017) · Macromolecular Bioscience · doi:10.1002/mabi.201600430 · Cited by 15
Integration of biological knowledge and gene expression data for biomarker selection
Amundson, S. A., & Smilenov, L. B. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.12.13731 · Cited by 15
Radiation Treatment Effects on the Proteome of the Tumour Microenvironment
Atkinson, M. J. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-5896-4_3 · Cited by 14
RAD9 enhances radioresistance of human prostate cancer cells through regulation of ITGB1 protein levels
Broustas, C. G., & Lieberman, H. B. (2014) · The Prostate · doi:10.1002/pros.22842 · Cited by 14
A Monoclonal Antibody Against β1 Integrin Inhibits Proliferation and Increases Survival in an Orthotopic Model of High-Grade Meningioma
Nigim, F., Kiyokawa, J., Gurtner, A., Kawamura, Y., Hua, L., Kasper, E. M., Brastianos, P. K., Cahill, D. P., Rabkin, S. D., Martuza, R. L., et al. (2019) · Targeted Oncology · doi:10.1007/s11523-019-00654-4 · Cited by 14
Rapid and automated multidimensional fluorescence microscopy profiling of 3D human breast cultures
Park, C. C., Georgescu, W., Polyzos, A. A., Pham, C. J., Ahmed, K. M., Zhang, H., & Costes, S. V. (2013) · Integrative Biology · doi:10.1039/c3ib20275e · Cited by 14
Self-citation
Pheophorbide A and SN38 conjugated hyaluronan nanoparticles for photodynamic- and cascadic chemotherapy of cancer stem-like ovarian cancer
Lee, J.-H., Davaa, E., Jiang, Y., Shin, K.-J., Kim, M. H., An, H., Kim, J., Cho, S. K., & Yang, S. (2022) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2022.119455 · Cited by 13
SCO-spondin-derived peptide NX210 rescues neurons from cerebral ischemia/reperfusion injury through modulating the Integrin-β1 mediated PI3K/Akt pathway
Yang, L., Zhu, J., Li, Y., Gan, Y., Hu, D., Zhao, J., & Zhao, Y. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109079 · Cited by 12
β1 Integrin Cytoplasmic Variants Differentially Regulate Expression of the Antiangiogenic Extracellular Matrix Protein Thrombospondin 1
Goel, H. L., Moro, L., Murphy-Ullrich, J. E., Hsieh, C., Wu, C., Jiang, Z., & Languino, L. R. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0186 · Cited by 12
A Computer-Assisted 3D Model for Analyzing the Aggregation of Tumorigenic Cells Reveals Specialized Behaviors and Unique Cell Types that Facilitate Aggregate Coalescence
Scherer, A., Kuhl, S., Wessels, D. J., Lusche, D. F., Hanson, B. M., Ambrose, J., Voss, E. R., Fletcher, E., Goldman, C. D., & Soll, D. R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118628 · Cited by 12
Coadministration of the FNIII14 Peptide Synergistically Augments the Anti-Cancer Activity of Chemotherapeutic Drugs by Activating Pro-Apoptotic Bim
Iyoda, T., Nagamine, Y., Nakane, Y., Tokita, Y., Akari, S., Otsuka, K., Fujita, M., Itagaki, K., Takizawa, Y.-I., Orita, H., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162525 · Cited by 11
Light Sheet Fluorescence Microscopy Applications for Multicellular Systems
Colombelli, J., & Lorenzo, C. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-409513-7.00008-7 · Cited by 11
4D Tumorigenesis Model for Quantitating Coalescence, Directed Cell Motility and Chemotaxis, Identifying Unique Cell Behaviors, and Testing Anticancer Drugs
Kuhl, S., Voss, E. R., Scherer, A., Lusche, D. F., Wessels, D. J., & Soll, D. R. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3480-5_18 · Cited by 11
IQGAP1 and NWASP promote human cancer cell dissemination and metastasis by regulating β1-integrin via FAK and MRTF/SRF
Cerutti, C., Lucotti, S., Menéndez, S. T., Reymond, N., Garg, R., Romero, I. A., Muschel, R. J., & Ridley, A. J. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113989 · Cited by 10
Enhancing 223Ra Treatment Efficacy by Anti-β1 Integrin Targeting
Paindelli, C., Casarin, S., Wang, F., Díaz-Gómez, L. A., Zhang, J., Mikos, A. G., Logothetis, C. J., Friedl, P., & Dondossola, E. (2021) · Journal of Nuclear Medicine · doi:10.2967/jnumed.121.262743 · Cited by 10
A novel computational predictive biological approach distinguishes Integrin β1 as a salient biomarker for breast cancer chemoresistance
Das, S., Kundu, M., Hassan, A., Parekh, A., Jena, B. C., Mundre, S., Banerjee, I., Rajesh, Y., Das, C. K., Pradhan, A. K., et al. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166702 · Cited by 10
Molecular Targeting of Integrins and Integrin-Associated Signaling Networks in Radiation Oncology
Vehlow, A., Storch, K., Matzke, D., & Cordes, N. (2016) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-662-49651-0_4 · Cited by 10
Matrix Stiffness Regulated Endoplasmic Reticulum Stress-mediated Apoptosis of Osteosarcoma Cell through Ras Signal Cascades
Deng, H., Shu, X., Wang, Y., Zhang, J., Yin, Y., Wu, F., & He, J. H. (2023) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-023-01184-7 · Cited by 9
Therapy-Naive and Radioresistant 3-Dimensional Pancreatic Cancer Cell Cultures Are Effectively Radiosensitized by β1 Integrin Targeting
Görte, J., Danen, E. H. J., & Cordes, N. (2021) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2021.08.035 · Cited by 9
Luteolin inhibits angiogenesis and enhances radiotherapy sensitivity of laryngeal cancer via downregulating Integrin β1
Li, Z., Ge, H., Xie, Y., Zhang, Y., Zhao, X., Sun, W. C., & Song, M. (2023) · Tissue and Cell · doi:10.1016/j.tice.2023.102235 · Cited by 8
β1 integrin- and JNK-dependent tumor growth upon hypofractionated radiation
Sayeed, A., Lu, H., Liu, Q., Deming, D., Duffy, A. N., McCue, P. A., Dicker, A. P., Davis, R. J., Gabrilovich, D. I., Rodeck, U., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10522 · Cited by 8
Microfluidic Mapping of Cancer Cell–Protein Binding Interaction
Liu, Z., Han, X., Chen, R., Zhang, K., Li, Y., Fruge, S., Jang, J. H., Ma, Y., & Qin, L. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b03728 · Cited by 8
Radiation-induced myosin IIA expression stimulates collagen type I matrix reorganization
Blockhuys, S., Rompaye, B. V., Rycke, R. M. D., Lambein, K., Claes, K., Bracke, M., Wagter, C. D., & Wever, O. D. (2013) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.04.001 · Cited by 8
Novel omics technology driving translational research in precision oncology
Basu, A., Budhraja, A., Juwayria, Abhilash, D., & Gupta, I. (2021) · Advances in genetics · doi:10.1016/bs.adgen.2021.08.003 · Cited by 7
Three‐Dimensional Culture
Freshney, R. I. (2010) · doi:10.1002/9780470649367.ch25 · Cited by 7
Epigenetics as a determinant of radiation response in cancer
Aréchaga-Ocampo, E. (2023) · International review of cytology · doi:10.1016/bs.ircmb.2023.07.008 · Cited by 7
Basement membranes in lung metastasis growth and progression
Torre-Cea, I., Berlana-Galán, P., Guerra-Paes, E., Cáceres-Calle, D., Carrera-Aguado, I., Marcos-Zazo, L., Sánchez‐Juanes, F., & Muñoz‐Félix, J. M. (2024) · Matrix Biology · doi:10.1016/j.matbio.2024.12.008 · Cited by 6
CD29 expressed on plasma cells is activated by divalent cations and soluble CD106 contained in the bone marrow plasma: refractory activation is associated with enhanced proliferation and exit of clonal plasma cells to circulation in multiple myeloma patients
Viñambres, E. M., García‐Trujillo, J. A., Rodríguez‐Martín, E., Villar, L. M., Coll, J., & Quirós-Roldán, E. (2011) · Leukemia · doi:10.1038/leu.2011.335 · Cited by 6
Apical integrins as a switchable target to regulate the epithelial barrier
Peterson, R. J., Reed, R. C., Zamecnik, C. R., Sallam, M. A., Finbloom, J. A., Martinez, F. J., Levy, J. M., Moonwiriyakit, A., Desai, T. A., & Koval, M. H. (2024) · Journal of Cell Science · doi:10.1242/jcs.263580 · Cited by 6
The not-so-sweet side of sugar: Influence of the microenvironment on the processes that unleash cancer
Mboge, M. Y., & Bissell, M. J. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165960 · Cited by 6
Self-citation
Systems approaches to uncovering the contribution of environment-mediated drug resistance
Creixell, M., Kim, H., Mohammadi, F., Peyton, S. R., & Meyer, A. S. (2022) · Current Opinion in Solid State and Materials Science · doi:10.1016/j.cossms.2022.101005 · Cited by 5
Deletion of the cell adhesion adaptor protein vinculin disturbs the localization of GFAP in Bergmann glial cells
Winkler, U., Hirrlinger, P., Sestu, M., Wilhelm, F., Besser, S., Zemljic-Harpf, A. E., Ross, R., Bornschein, G., Krügel, U., Ziegler, W., et al. (2013) · Glia · doi:10.1002/glia.22495 · Cited by 3
Integrin β1 in breast cancer: mechanisms of progression and therapy
Huang, Q., Wang, J., Ning, H., Liu, W., & Han, X. (2024) · Breast Cancer · doi:10.1007/s12282-024-01635-w · Cited by 4
3D Radiation Biology for Identifying Radiosensitizers
Vehlow, A., Deville, S. S., & Cordes, N. (2020) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-030-49701-9_6 · Cited by 4
Somatic Mutations Favorable to Patient Survival Are Predominant in Ovarian Carcinomas
Zhang, W., Edwards, A., Flemington, E. K., & Zhang, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112561 · Cited by 3
Knockdown of CSNK2β suppresses MDA-MB-231 cell growth, induces apoptosis, inhibits migration and invasion
Karna, S. K. L., Lone, B. A., Ahmad, F., Shahi, N., & Pokharel, Y. R. (2020) · EXCLI journal · doi:10.17179/excli2020-2363 · Cited by 4
Characterization of Oncogenic and Immunogenic Profiling in Patients with Breast Cancer Tumors After Radiation Therapy
Niture, S. K., Vargas, C. E., Chumsri, S., Kachergus, J. M., Sriramanujam, S., Thotala, D. K., Jaboin, J. J., & Seneviratne, D. S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27073227 · Cited by 2
Mechanobiology of the tumor microenvironment: a review of therapeutic interactions and in vitro elasticity measurement techniques
Chen, T.-W., Yu, S., Lu, S.-L., Yeh, C.-H., & Li, P. (2026) · Journal of Biomedical Science · doi:10.1186/s12929-026-01270-x · Cited by 2
Comparative Ultrastructure Analysis of Radiation-induced Radioresistant Laryngeal Cancer Hep-2 Cell Line
Yang, B., Tang, F., Zhang, B., Zhao, Y., Ding, S., & Rao, Z. (2014) · Ultrastructural Pathology · doi:10.3109/01913123.2014.897283 · Cited by 2
The Journal Of Stomatological Investigation
Cirillo, N. (2010) · Bristol Research (University of Bristol) · Cited by 2
Molecular Imaging and Radiobiology
Shaikh, S. (2022) · Springer eBooks · doi:10.1007/978-981-16-9535-3_22 · Cited by 2
Triple-negative mouse breast cancer initiating cells show high expression of beta1 integrin and increased malignant features
Fu, J., & Peng, S. (2023) · Open Life Sciences · doi:10.1515/biol-2022-0510 · Cited by 2
Robustness of integrin signaling network
Kness, M., Wang, G., & Zaman, M. H. (2009) · The Journal of Chemical Physics · doi:10.1063/1.3149857 · Cited by 2
Antibodies targeting Cancer stem cells, A novel pattern in ImmunotherapyPreprint
Alam, S., & Alam, S. (2010) · Nature Precedings · doi:10.1038/npre.2010.5428.1 · Cited by 1
Three-Dimensional Culture
Ahmed, K. M. (2017) · Springer eBooks · doi:10.1007/978-3-662-46875-3_7138 · Cited by 2

Authors: Park, C. C., Zhang, H. J., Yao, E. S., Park, C. J., & Bissell, M. J.
Affiliations: University of California, San Francisco (US)
Lawrence Berkeley National Laboratory (US)
ORCID: Park, Catherine C.
Bissell, Mina J.
Venue: Cancer Research
Publisher: American Association for Cancer Research (AACR)
Published: 2008-06-01
Volume: 68
Issue: 11
Pages: 4398-4405
ISSN: 0008-5472 (ISSN-L)
1538-7445
DOI: 10.1158/0008-5472.can-07-6390
PMC: PMC3719863
OpenAlex: W1968324001
Cited by: 220
References: 43
Citations by year: 2026: 6 · 2025: 3 · 2024: 8 · 2023: 10 · 2022: 12 · 2021: 15 · 2020: 9 · 2019: 10 · 2018: 12 · 2017: 14 · 2016: 13 · 2015: 13 · 2014: 20 · 2013: 19 · 2012: 18
FWCI: 8.20
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Cancer Research (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
eScholarship (California Digital Library) (submittedVersion)
University of North Texas Digital Library (University of North Texas) (submittedVersion)
OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
Funders: U.S. Department of Defense (DE-AC02-05CH11231)
U.S. Department of Energy (-AC02-05CH11231, DE-AC03-?, AC03-76SF00098, DEAC03-76SF00098, 05CH11231, DE AC02 05CH11231, DE-AC02-)
National Institutes of Health (DE-AC02–05CH11231, NIH P50, DE-AC03- 76SF00098)
University of California, San Francisco
National Cancer Institute (R01CA124891, CA64786-09, CA-58207, R37CA064786, P50CA058207, R01CA064786, CA CA58207-08, DE-AC02-05CH11231)
Biological and Environmental Research (05CH11231, DE-AC02 − 05CH11231, AC02-05CH11231)
Topics: Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Effects of Radiation Exposure
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Keywords: beta1 integrin, radiotherapy, breast cancer, Akt signaling, radioresistance (biology), apoptosis, MCF-7 xenografts, tumor growth inhibition, radiosensitization
MeSH terms: Breast, Breast Neoplasms, Cell Line, Cell Separation, Humans, Transplantation, Heterologous, Blotting, Western, Treatment Outcome, Apoptosis, Microscopy, Confocal, Integrin beta1, In Situ Nick-End Labeling, Cell Proliferation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

β1 Integrin Inhibition Dramatically Enhances Radiotherapy Efficacy in Human Breast Cancer Xenografts

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks